CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Exercise or conversion · Options to Buy Ordinary Shares | −5,517 | 0 | ||
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Exercise or conversion · Options to Buy Ordinary Shares | −7,183 | 10,479 | ||
| 2023-01-05 | Leonard Frank X President, CNS Cancers US | Exercise or conversion · Options to Buy Ordinary Shares | −7,183 | 17,662 | ||
| 2023-01-05 | Shah Pritesh Chief Commercial Officer | Sale | −387 | $108.00 | $42K | 82,843 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Exercise or conversion | +25,000 | $11.46 | $287K | 38,583 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Sale | −8,369 | $111.23 | $931K | 30,214 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Sale | −2,000 | $112.86 | $226K | 28,214 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Sale | −4,568 | $114.35 | $522K | 23,646 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Sale | −3,702 | $115.21 | $427K | 19,944 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Sale | −1,395 | $116.06 | $162K | 18,549 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Sale | −999 | $117.01 | $117K | 17,550 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Sale | −2,123 | $118.47 | $252K | 15,427 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Sale | −1,344 | $119.35 | $160K | 14,083 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Sale | −500 | $119.99 | $60K | 13,583 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Exercise or conversion | +187,500 | $7.15 | $1.3M | 201,083 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Sale | −187,500 | $108.00 | $20.3M | 13,583 |
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Exercise or conversion · Options to Buy Ordinary Shares | −25,000 | 0 | ||
| 2023-01-05 | Danziger Asaf Chief Executive Officer | Exercise or conversion · Options to Buy Ordinary Shares | −187,500 | 0 | ||
| 2022-12-02 | Cordova Ashley Chief Financial Officer | Exercise or conversion | +2,000 | $7.15 | $14K | 74,376 |
| 2022-12-02 | Cordova Ashley Chief Financial Officer | Exercise or conversion · Options to Buy Ordinary Shares | −2,000 | $7.15 | $14K | 7,752 |
Page 18 of 20 · 399 trades